MiR-125a-3p alleviates hyperproliferation of keratinocytes and psoriasis-like inflammation by targeting TLR4/NF-κB pathway.

Authors:
Jin Z; Huang Q; Peng J; Liu Z; Hu R and 2 more

Journal:
Postepy Dermatol Alergol

Publication Year: 2023

DOI:
10.5114/ada.2023.129155

PMCID:
PMC10399661

PMID:
37545827

Journal Information

Full Title: Postepy Dermatol Alergol

Abbreviation: Postepy Dermatol Alergol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"The work was supported by a scientific research project of Wuhan Municipal Health Commission (Approval number: WX21A13)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025